Stage 4S neuroblastoma: what makes it special? - PubMed (original) (raw)

Editorial

Stage 4S neuroblastoma: what makes it special?

K K Matthay. J Clin Oncol. 1998 Jun.

No abstract available

PubMed Disclaimer

Similar articles

• High affinity nerve growth factor receptor expression (gp140trkA), N-myc amplification, histopathology, and survival in neuroblastoma.
  Miyake M, Suzuki T, Shimada H, Stram D, Seeger RC. Miyake M, et al. Prog Clin Biol Res. 1994;385:163-8. Prog Clin Biol Res. 1994. PMID: 7972208 No abstract available.
• NGF induces terminal differentiation in trkA expressing neuroblastoma cells in vitro and in vivo.
  Matsushima H, Bogenmann E. Matsushima H, et al. Prog Clin Biol Res. 1994;385:177-83. Prog Clin Biol Res. 1994. PMID: 7972210 No abstract available.
• Clinical significance of expression of neurotrophic factors and their receptors in neuroblastoma.
  Nakagawara A, Arima-Nakagawara M, Azar CG, Scavarda NJ, Brodeur GM. Nakagawara A, et al. Prog Clin Biol Res. 1994;385:155-61. Prog Clin Biol Res. 1994. PMID: 7972207 No abstract available.
• [Biological markers for the prognosis of neuroblastoma: proposal of a method of analysis].
  Combaret V, Delattre O, Bénard J, Favrot MC. Combaret V, et al. Bull Cancer. 1998 Mar;85(3):262-6. Bull Cancer. 1998. PMID: 9752317 Review. French.
• [Neuroblastoma].
  Sawada T, Komatsu H, Shirai C, Yamamoto S, Ishiwari K, Ishida H, Ohmizono Y, Matsumura T. Sawada T, et al. Gan To Kagaku Ryoho. 1995 Jan;22(1):28-36. Gan To Kagaku Ryoho. 1995. PMID: 7826075 Review. Japanese.

Cited by

• Revisiting the role of radiotherapy in the treatment of neuroblastoma 4S: 30 years of institutional experience and systematic review.
  Wawrzuta D, Chojnacka M, Dembowska-Bagińska B, Raciborska A, Hutnik Ł, Cieślak M, Pędziwiatr K. Wawrzuta D, et al. Clin Transl Radiat Oncol. 2024 May 5;47:100791. doi: 10.1016/j.ctro.2024.100791. eCollection 2024 Jul. Clin Transl Radiat Oncol. 2024. PMID: 38745962 Free PMC article.
• Integrative analysis with machine learning identifies diagnostic and prognostic signatures in neuroblastoma based on differentially DNA methylated enhancers between INSS stage 4 and 4S neuroblastoma.
  Li S, Mi T, Jin L, Liu Y, Zhang Z, Wang J, Wu X, Ren C, Wang Z, Kong X, Liu J, Luo J, He D. Li S, et al. J Cancer Res Clin Oncol. 2024 Mar 21;150(3):148. doi: 10.1007/s00432-024-05650-4. J Cancer Res Clin Oncol. 2024. PMID: 38512513 Free PMC article.
• Characterization and therapeutic perspectives of differentiation-inducing therapy in malignant tumors.
  Zhu K, Xia Y, Tian X, He Y, Zhou J, Han R, Guo H, Song T, Chen L, Tian X. Zhu K, et al. Front Genet. 2023 Sep 8;14:1271381. doi: 10.3389/fgene.2023.1271381. eCollection 2023. Front Genet. 2023. PMID: 37745860 Free PMC article. Review.
• NTRK1/TrkA Activation Overrides the G2/M-Checkpoint upon Irradiation.
  Hassiepen C, Soni A, Rudolf I, Boron V, Oeck S, Iliakis G, Schramm A. Hassiepen C, et al. Cancers (Basel). 2021 Nov 30;13(23):6023. doi: 10.3390/cancers13236023. Cancers (Basel). 2021. PMID: 34885133 Free PMC article.
• Spontaneous regression of neuroblastoma.
  Brodeur GM. Brodeur GM. Cell Tissue Res. 2018 May;372(2):277-286. doi: 10.1007/s00441-017-2761-2. Epub 2018 Jan 5. Cell Tissue Res. 2018. PMID: 29305654 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Medical

  • MedlinePlus Health Information